Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - gastric+cancer
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Use of nucleotide synthesis inhibitors for targeted therapy in MLL3/4 COMPASS mutant cancer
NU 2022-053 INVENTORS Ali Shilatifard (Feinberg School of Medicine, Department of Biochemistry and Molecular Genetics)* Zibo Zhao (Feinberg School of Medicine, Department of Biochemistry and Molecular Genetics)* SHORT DESCRIPTION A therapeutic platform that targets MLL3/4 COMPASS mutant cancers by using nucleotide synthesis inhibitors to disrupt...
Published: 4/29/2026
|
Updated: 4/29/2026
|
Inventor(s):
Keywords(s):
Bladder cancer
,
Breast cancer
,
Cancer/Oncology
,
Colon cancer
,
Gastric cancer
,
Leukemia
,
Lung cancer
,
Lymphoma
,
Prostate cancer
,
Targeted therapy
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
STING Agonist 8803 for Blood-Brain Barrier Opening in Glioblastoma Treatment
SHORT DESCRIPTION Chemical compound that opens the blood-brain barrier to enhance delivery of therapeutics for treating glioblastoma. INVENTORS Amy Heimberger* Northwestern University Feinberg School of Medicine, Department of Neurological Surgery * Principal Investigator NU 2025-212 IP...
Published: 4/29/2026
|
Updated: 4/27/2026
|
Inventor(s):
Keywords(s):
AD - Alzheimer’s Disease
,
Adjunct therapy
,
ALS - Amyotrophic Lateral Sclerosis
,
Animal Model
,
Autoimmune disease
,
Bladder cancer
,
Brain cancer
,
Breast cancer
,
Cancer Treatment
,
Cancer/Oncology
,
Cervical cancer
,
CNS - Central Nervous System
,
Colon cancer
,
Drug delivery
,
Endometrial cancer
,
Gastric cancer
,
GBM - Glioblastoma
,
Head and neck cancer
,
Immunology
,
Immunotherapy
,
Liver cancer
,
Lung cancer
,
MS - Multiple Sclerosis
,
Neurodegenerative disease
,
Neurologic disease
,
Ovarian cancer
,
Pancreatic cancer
,
PD - Parkinson's Disease
,
Prostate cancer
,
Repurposed Drugs
,
Research tool
,
Small molecule
,
Targeted therapy
,
TBI - Traumatic brain injury
,
Therapeutics
Category(s):
Life Sciences > Therapeutics
,
Life Sciences > Biomarkers & Biomedical Research Tools
Anti-CD73 Monoclonal Antibody for Enhanced Cancer Immunotherapy
NU 2020-207 INVENTORS Bin Zhang* Siqi Chen Jie Fan SHORT DESCRIPTION This invention comprises novel anti-CD73 monoclonal antibody compositions that recognize and inhibit mouse and human CD73. BACKGROUND CD73, an ecto-enzyme associated with adenosine metabolism, is an emerging immune checkpoint that promotes tumor progression by suppressing...
Published: 12/11/2025
|
Updated: 1/30/2025
|
Inventor(s):
Keywords(s):
Brain cancer
,
Breast cancer
,
Cancer/Oncology
,
Colon cancer
,
Gastric cancer
,
Immunotherapy
,
Lung cancer
,
Ovarian cancer
,
Pancreatic cancer
,
Therapeutics
Category(s):
Life Sciences > Therapeutics